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Muscular degeneration in the absence of dystrophin is a calcium-
dependent process
Marie-Christine Mariol and Laurent Se´galat
Duchenne muscular dystrophy (DMD) is a source of controversy over the years, since increases of
global sarcolemmal Ca2 concentration in mdx mouse fi-progressive degenerative muscular disease that is
bers have been observed by some groups and not bydue to mutations in the dystrophin gene [1]. Neither
others (reviewed in [8]). However, recently, two groupsthe function of dystrophin nor the physiopathology
used Ca2 sensors able to measure Ca2 levels locally inof the disease have been clearly established yet.
cellular compartments and reported higher Ca2 concen-Several groups have reported elevated calcium
tration in mdx fibers [4, 9]. Meanwhile, Campbell andconcentrations in the mdx mouse model of DMD,
collaborators were able to reduce cardiomyopathy in sar-but the effect of calcium levels on the progression of
coglycan-deficient mice, which resemble mdx mice, bythe disease continues to be a matter of debate [2–4].
chronic treatment with the calcium channel blocker vera-Here, we show that, in Caenorhabditis elegans, a
pamil [10]. Surprisingly, however, this treatment had nogain-of-function mutation in the egl-19 calcium
effect on mdx mice.channel gene dramatically increases muscle
degeneration in dystrophin mutants. Conversely,
The nematode Caenorhabditis elegans possesses a dys-RNAi-mediated inhibition of egl-19 function
trophin-like gene, as well as several genes homologous toreduces muscle degeneration by half. Therefore, our
members of the DGC complex [11, 12]. In C. elegans,results demonstrate that calcium channel activity
mutations of the dystrophin gene (dys-1) lead to a subtleis a critical factor in the progression of dystrophin-
and specific phenotype consisting of hyperactivity, hyper-dependent muscle degeneration.
contraction, and exaggerated bending of the head when
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To test whether calcium channel activity plays a role in
dystrophin-dependent muscle degeneration, we con-
structed dys-1; egl-19 double mutants with both loss- and
gain-of-function alleles of egl-19. egl-19 is the major volt-
Background age-gated calcium channel of C. elegans muscles. egl-19
Dystrophin is the product of the gene mutated in Du- loss-of-functionmutations cause lethality or flaccid paraly-
chenne muscular dystrophy (DMD), an inherited disease sis, whereas gain-of-function mutations are myotonic [14].
in which muscle fibers progressively degenerate [1]. Dys- We used alleles n582 and ad695, which have been geneti-
trophin is a large cellular protein located under the muscle cally defined as partial loss-of-function and gain-of-func-
sarcolemma and is bound to a complex of proteins (DGC) tion alleles, respectively [14, 15]. Both mutations have
that spans the membrane and includes dystroglycans and been mapped to the IIIS4 segment of the channel, which
sarcoglycans [5]. The function of dystrophin is not clearly is supposed to be part of the voltage sensor of the channel
understood yet [6]. The mechanisms underlying muscle [14]. dys-1(cx18); egl-19(n582) animals behaved similarly
degeneration in DMD patients are still debated. to egl-19(n582) animals, which are slow and egg laying
defective (egl). This result first indicates that the dys-1
Several authors have proposed that muscle degeneration phenotype is suppressed by egl-19(n582). In contrast, dys-
is due to elevated intracellular calcium levels that could 1(cx18); egl-19(ad695) animals were short, hypercon-
either poison the cells, stimulate calcium-dependent pro- tracted, and tended to become uncoordinated (unc) when
teases, or activate signal transduction pathways that are they aged. Some adults appeared coiled and were severely
paralyzed.noxious to the cell [7]. This hypothesis has been the
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Table 1
Muscle degeneration in dys-1 and egl-19 animals.
Number of abnormal Number of abnormal
body wall muscles body wall muscles
Genotype (day 7) (day 10)
Wild-type N2 0  0 0  0
dys-1(cx18) 0  0 0.1  0.1
egl-19(ad695) 0  0 0.1  0.1
egl-19(n582) 0  0 0  0
dys-1(cx18); egl-19(n582) 0  0 NT
dys-1(cx18); egl-19(ad695) 1.7  2 4.3  4.4
dys-1(cx18); egl-19(ad695)  RNAi egl-19 0.2  0.1 NT
dys-1(cx18); hlh-1(cc561) 11.1  2.8 NT
dys-1(cx18); hlh-1(cc561)  RNAi egl-19 4.6  2.3 NT
Number of abnormal or missing body wall muscle cells per animal in high standard deviations. All strains were grown at 15C. egl-19
(mean values  s.d.). Only the two most visible quadrants of RNAi was administered by feeding animals with E. coli producing
body wall muscles in each animal were scored (40 cells per animal). dsRNA. NT: not tested.
In some cases, the high variability of phenotypes resulted
We looked at the musculature of animals at day 4, 7, and 19(ad695) animals is not due to a genetic heterogeneity
of the strain, but rather to stochastic variations from one10, corresponding approximately to the larval L4 stage,
and day 2 and 5 of adulthood (Table 1 and Figure 1). dys-1 animal to another. Since body wall muscle cells are electri-
cally coupled, it is possible that degradation of a significantmutants exhibit very little muscle degeneration (1% of
cells), and this is seen only in 10-day animals.We observed number of cells in an animal renders remaining cells more
prone to degeneration.similar results for egl-19(ad695) animals, in which rare
degenerating muscle cells are visible only at 10 days.
Degenerating cells were not observed in either egl- Since elevated levels of egl-19 activity dramatically in-
19(n582) animals or in the dys-1(cx18); egl-19(n582) double-
mutant animals (Table 1). In contrast, muscle degenera-
Figure 1tion was high in dys-1(cx18); egl-19(ad695) animals and
increased over time (Table 1 and Figure 1). The animals
that displayed the coiled appearance on the plate were
those in which the percentage of abnormal muscle cells
was the highest. Abnormal cells were characterized by
disrupted actin filaments, aggregates of actin, or complete
loss of the cell (Figure 2a–e).
The number of degenerating cells in dys-1(cx18); egl-
19(ad695) animals displays wide variations between ani-
mals (Figure 1). This could have been the result of genetic
heterogeneity amongst the animals. To test this, we per-
formed two types of experiments. First, we cloned ten of
the less affected animals and ten of the most affected
animals on single plates and looked at their progeny (data
not shown). The progenies in the two groups were identi-
cal, each plate giving rise to both mildly affected and
severely affected animals. Second, we reduced egl-19 ac-
tivity in the dys-1(cx18); egl-19(ad695) animals by the
RNAi feeding technique [16], using bacteria producing Muscle degeneration in dys-1(cx18); egl-19(ad695) animals. A
dsRNA against egl-19. These animals recovered a weak histogram of the number of abnormal or missing body wall muscle
cells in dys-1(cx18) (green circles), egl-19(ad695) (red triangles),dys-1 behavioral phenotype, intermediate between dys-
and dys-1(cx18); egl-19(ad695) (blue squares) animals at day 4, 7,1(cx18) and dys-1(cx18); egl-19(n582), indicating that egl-
and 10. More than 30 animals were observed in each category. The19 activity was diminished (data not shown). The number size of the symbols represent the number of points for a given value.
of abnormal muscle cells in these animals returned to near Only the two most visible quadrants of body wall muscles in each
animal were quantitated (40 cells per animal).wild-type levels (Table 1). Therefore, these experiments
show that the heterogeneity observed in dys-1(cx18); egl-
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Figure 2 Taken together, our results demonstrate that calcium
channel activity is directly correlated with the progression
of muscle degeneration induced by dystrophin mutations
in C. elegans. These results corroborate the potential role
of calcium in the progression of DMD.
Materials and methods
Strains
dys-1(cx18) is a putative null allele of the dystrophin-like dys-1 gene
[11]. hlh-1(cc561) is a temperature-sensitive mild allele of hlh-1 [17].
The dys-1(cx18); hlh(cc561) double mutant was described in [13]. egl-
19 alleles n582 and ad695 are described in [14]. All strains were grown
at 15C.
Staining
Phalloidin staining on adult animals was performed as in [13]. Only the
two most visible quadrants of body wall muscles in each animal were
quantitated (40 cells per animal). More than 30 animals were observed
in each category.
RNAi
RNAi against egl-19 was performed by cloning a 1.5-kb genomic frag-
ment of egl-19 (position 17400–18900 of cosmid C48A7) in plasmid
L4440 (containing a double T7 promoter) and transforming the construct
in Escherichia coli strain HT115 [16]. Induction of dsRNA production
was performed as in [18].
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